XLRN - Acceleron Pharma - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $8.34. This is a potential upside of $8.34 (0%) from yesterday's end of day stock price of $0.

Acceleron Pharma's activity chart (see below) currently has 192 price targets and 123 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 85.92% with an average time for these price targets to be met of 197.45 days.

Most recent stock forecast was given by AKASH TEWARI from JEFFERIES on 06-Oct-2021. First documented stock forecast 14-Aug-2014.

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

Since 06-Oct-2021

$180

$1.25 (0.70%)

4 years 3 months 2 days ago
(06-Oct-2021)

0/2 (0%)

$4.71 (2.69%)

Hold

Since 30-Sep-2021

$180

4 years 3 months 3 days ago
(05-Oct-2021)

16/17 (94.12%)

$7.9 (4.59%)

257

Hold

Since 01-Oct-2021

$180

$1.25 (0.70%)

$173

4 years 3 months 7 days ago
(01-Oct-2021)

6/7 (85.71%)

$5.65 (3.24%)

201

Buy

Since 10-Jul-2018

$150

$-28.75 (-16.08%)

$150

4 years 3 months 7 days ago
(01-Oct-2021)

8/9 (88.89%)

$-24.35 (-13.97%)

284

Hold

Since 23-Mar-2021

$180

$1.25 (0.70%)

$148

4 years 3 months 7 days ago
(01-Oct-2021)

7/8 (87.5%)

$5.65 (3.24%)

289

Show more analysts

Please expand the browser size to see the chart

What is XLRN (Acceleron Pharma) average time for price targets to be met?

On average it took 197.45 days on average for the stock forecasts to be realized with a an average price target met ratio 85.92

Which analyst has the current highest performing score on XLRN (Acceleron Pharma) with a proven track record?

YARON WERBER

Which analyst has the most public recommendations on XLRN (Acceleron Pharma)?

Yaron Werber works at TD COWEN and has 12 price targets and 5 ratings on XLRN

Which analyst is the currently most bullish on XLRN (Acceleron Pharma)?

Jeffrey Hung with highest potential upside - $1.25

Which analyst is the currently most reserved on XLRN (Acceleron Pharma)?

Geoff Meacham with lowest potential downside - -$133.75

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?